The Australian Medical Association Limited and state AMA entities comply with the Privacy Act 1988. Please refer to the AMA Privacy Policy to understand our commitment to you and information on how we store and protect your data.



28 Nov 2019

On 1 December 2019, a take home naloxone (THN) pilot – which aims to provide people who may be at risk of an opioid overdose, or are likely to witness an overdose, with free and easy access to naloxone – will launch in New South Wales, South Australia and Western Australia.

Each participating state will identify where naloxone will be available. Sites could include community and hospital-based pharmacies, alcohol and drug treatment centres, needle and syringe programs or other agreed non-pharmacy settings.

The THN pilot will be delivered in conjunction with the various THN programs currently operating in the participating states and provides a great opportunity to increase access to naloxone for people at risk.

Currently, naloxone is available in all states and territories with a prescription, or over the counter from a pharmacy for a fee.

For more information visit the Department THN pilot website.

Published: 28 Nov 2019